Various typing methods of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients;Différentes méthodes de typage des souches de Pseudomonas aeruginosa isolées des patients atteints de mucoviscidose

Medecine et Maladies Infectieuses

Volumn 38, Issue 5, 2008, Pages 238-247

  Hafiane, A ^a   Ravaoarinoro, M ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cystic fibrosis; Genotyping; Phenotyping; Pseudomonas aeruginosa

Indexed keywords

BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; COST CONTROL; CYSTIC FIBROSIS; ENDEMIC DISEASE; EPIDEMIC; GENOTYPE; GRAM NEGATIVE INFECTION; HEALTH CARE POLICY; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INTERMETHOD COMPARISON; MICROBIOLOGICAL EXAMINATION; MOLECULAR TYPING; NONHUMAN; PHENOTYPE; PSEUDOMONAS AERUGINOSA; RELIABILITY; REPRODUCIBILITY; REVIEW; STRAIN IDENTIFICATION; WORKLOAD;

CYSTIC FIBROSIS; GENE AMPLIFICATION; GENES, BACTERIAL; HUMANS; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 44649202792     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2008.02.005     Document Type: Review

References (93)

1. Hoiby N., Flensborg E.W., Beck B., Friis B., Jacobsen S.V., and Jacobsen L. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipintins determined by means of crossed immunoelectrophoresis. Scand J Resp Dis 58 (1977) 65-79
2. Ojeniyi B., and Hoiby N. Comparaison of different typing methods of Pseudomonas aeruginosa. Antibiot Chemother 44 (1991) 13-22
3. Ojeniyi B., Wolz C., Doring G., Lam J.S., Rosdahl V.T., and Hoiby N. Typing of polyagglutinable isolates from cystic fibrosis patients. APMIS 98 (1990) 423-431
4. Campbell M.E., Farmer S.W., and Speert D.P. New selective medium for Pseudomonas aeruginosa with phenanthroline and 9-chloro-9-[4-(diethylamino)phenyl]-9,10-dihydro-10-phenylacridine hydrochloride (C-390). J Clin Microbiol 26 (1988) 1910-1912
5. Penketh A., Pitt T., Roberts D., Hodson M.E., and Batten J.C. The relationship of phenotype change in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis. Am Rev Respir Dis 127 (1983) 605-608
6. Cheng K., Smyth R.L., Govan J.R., Doherty C., Winstanley C., Denning N., et al. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 348 (1996) 639-642
7. Singh A., Goering R.V., Simjee S., Foley S.L., and Zervos M. Application of molecular techniques to the study of hospital infection. Clin Microbiol Rev 19 (2006) 512-530
8. Michaele Olive D., and Bean P. Principles and applications of methods for DNA based typing of microbial organisms. J Clin Microbiol 37 (1999) 1661-1669
9. Mahenthiralingham E., Campbell M.E., Foster J., Lam J.S., and Speert D.P. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J Clin Microbiol 34 (1996) 1129-1135
10. Syrmis M.W., O'Carroll M.R., Sloots T.P., Coulter C., Wainwright C.E., Bell S.C., et al. Rapid genotyping of Pseudomonas aeruginosa isolates harboured by adult and paediatric patients with cystic fibrosis using repetitive-element-based PCR assays. J Med Microbiol 53 (2004) 1089-1096
11. Curran B., Jonas D., Grundman H., Pitt T., and Dowson C.G. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol 42 (2004) 5644-5649
12. Romling U., and Tummler B. Achieving 100% typeability of Pseudomonas aeruginosa by pulsed-field gel electrophoresis. J Clin Microbiol 38 (2000) 464-465
13. Loutit J.S., and Tompkins L.S. Restriction enzyme and southern hybridization analyses of Pseudomonas aeruginosa strains from patients with cystic fibrosis. J Clin Microbiol 29 (1991) 2897-2900
14. Olge J.W., Janda J.M., Woods D.E., and Vasil M.L. Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa. J Infect Dis 155 (1987) 119-126
15. Carpentier J.P., Morillon M., Petrognani R., and Cavallo J.D. Infections à bacille pyocyanique. Encycl Med Chir (2003) 8-025-B-50
16. Anzai Y., Kim H., Park J.Y., Wakabayashi H., and Oyaizu H. Phylogenetic affiliation of the pseudomal based on 16S rRNA sequence. Int J Syst Evol Microbiol 50 (2000) 1563-1589
17. Swings J., De Vos P., van Den Mooter M., and De Ley J. Transfer of Pseudomonas maltophilia Hugh 1981, to the genus Xanthomonas as Xanthomonas maltophilia (Hugh 1981) comb.nov. Int J Syst Bacteriol 33 (1983) 409-413
18. Fox G.E., Wisotzkey J.D., and Jurtshuk P.J. How close is close: 16S rRNA sequence identity may not be sufficient to guarantee species identity. Int J Syst Bacteriol 42 (1992) 166-170
19. Ojeniyi B. Polyagglutinable Pseudomonas aeruginosa from cystic fibrosis patients. A survey. APMIS Suppl 46 (1994) 1-44
20. Spikler T., Coenye T., Vandamme P., and Lipuma J.J. PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients. J Clin Microbiol 42 (2004) 2074-2079
21. Grundman H., Schneider C., Hartung D., Daschner F.D., and Pitt T.L. Discriminatory power of three DNA-based typing technique of Pseudomonas aeruginosa. J Clin Microbiol 33 (1995) 528-534
22. Millesimo M., de Intinis G., Chirillo M.G., Musso T., and Savoia D. Pseudomonas aeruginosa: serotypes, resistance phenotypes and plasmid profiles. Eur J Epidemiol 12 (1996) 123-129
23. Speert D.P., Campbell M.E., Farmer S.W., Volpel K., Joffe A.M., and Paranchych W. Use of a pilin gene probe to study molecular epidemiology of Pseudomonas aeruginosa. J Clin Microbiol 27 (1989) 2589-2593
24. Liu P.V., Matsumoto H., and Bergan T. Survery of heat-stable major somatic antigens of Pseudomonas aeruginosa. Int J Syst Bacteriol 33 (1983) 256-264
25. Govan J.R.W. Pyocin typing of Pseudomonas aeruginosa. In: Bergan T., and Norris J.R. (Eds). Method in microbiology 10 (1978), Academic Press, London and New York 61-91
26. Gould J.C., and McLeod J.W. A study of the use of agglutinating sera and phage lysis in the classification of strains of Pseudomonas aeruginosa. J Pathol Bacteriol 79 (1960) 295-311
27. Wu F., and Della-Latta P. Molecular typing strategies. Semin Perinatol 26 (2002) 357-366
28. Pitt T.L. State of the art: typing Pseudomonas aeruginosa. J Hosp Infect 1 (1980) 193-199
29. Freitas A.L., and Barth A.L. Typing of Pseudomonas aeruginosa from hospitalised patients: a comparison of susceptibility and biochemical profiles with genotype. Braz J Med Res 37 (2004) 77-82
30. Ader F., Le Berre R., Faure K., Gosset P., Epaulard O., Toussaint B., et al. Alveolar Response to Pseudomonas aeruginosa: role of the type III secretion system. Infect Immun 73 (2005) 4263-4271
31. Xu J., Moore J.E., Murphy P.G., Millar B.C., and Elborn J.S. Early detection of Pseudomonas aeruginosa comparison of conventional versus molecular (PCR) detection directly from adult patients with cystic fibrosis (CF). Ann Clin Microbiol Antimicrob 20 (2002) 3-21
32. Pitt T.L. Epidemiological typing of Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis 7 (1988) 238-247
33. Amann R.I., Ludwing W., and Schleifer K.H. Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol Rev 59 (1995) 149-169
34. Tramper-Stranders G.A., van Der Ent C.K., and Wolfs T.F. Detection of Pseudomonas aeruginosa in patients with cystic fibrosis. J Cyst Fibros 4 Suppl. 2 (2005) 37-43
35. Pitt T.L., MacDougall J., Penketh A.R.L., and Cooke E.M. Polyagglutinating and non-typable strains of Pseudomonas aeruginosa in cystic fibrosis. J Med Microbiol 21 (1986) 179-186
36. Hancock R.E., Mutharia M., Chan L., Darveau L.P., Speert D., and Pier G.B. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, non typable strains deficient in lipopolysaccharide O side chains. Infect Immun 42 (1983) 170-177
37. Soler C.P., Gidenne S., Saint-blanchard P., Kerleguer A., and Gerome P. Recovery method of serotypable character in non serotypable Pseudomonas aeruginosa strains. Pathol Biol (Paris) 52 (2004) 33-38
38. Speert D. Molecular epidemiology of Pseudomonas aeruginosa. Front Biosci 7 (2002) 354-361
39. Hoiby N., and Rosendal K. Epidemiology of Pseudomonas aeruginosa infection in patients treated at a cystic fibrosis centre. Acta Pathol Microbiol Immunol Scand [B] 88 (1980) 125-131
40. National Committee for Clinical Laboratory Standard. Performance standards for antimicrobial disk susceptibility tests, 7th ed. Approved standard M2-A7. National Committee for Clinical Laboratory Standards, Wayne, PA; 2000a
41. Jones R.N., Biedenbach D.J., Marshall S.A., Pfaller M.A., and Doern G.V. Evaluation of the Vitek system to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepime. Diagn Microbiol Infect Dis 32 (1998) 107-110
42. Bellon G., and Gilly R. Antibiothérapie dans la mucoviscidose : incertitudes et réalités. Rev Mal Resp 7 (1990) 203-208
43. Saiman L., Burns J.L., Whittier S., Krzewinski J., Erwin M., Marshall S., et al. Evaluation of reference dilution test methods for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from patients with cystic fibrosis. J Clin Microbiol 37 (1999) 2987-2991
44. Burns J.L., Saiman L., Whittier S., Larone D., Krzewinski J., Liu Z., et al. Comparison of agar diffusion methodologies for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from patients with cystic fibrosis. J Clin Microbiol 38 (2000) 1818-1822
45. Burns J.L., Saiman L., Whittier S., Krzewinski J., Liu Z., Larone D., et al. Comparison of two commercial systems (vitek and microscan-walkaway) for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients. Diagn Microbiol Infect Dis 39 (2001) 257-260
46. Fegan M., Francis P., Hayward A.C., Davis G.H.G., and Fuerst J.A. Phenotypic conversion of Pseudomonas aeruginosa in cystic fibrosis. J Clin Microbiol 28 (1990) 1143-1146
47. van Horn K.G. Mixed-morphotype broth microdilution susceptibility testing of P. aeruginosa from cystic fibrosis patients. J Clin Microbiol 31 (1993) 458-459
48. Mereghetti L., Marquet-van der Mee N., Loulergue J., Rolland J.C., and Audurier A. Pseudomonas aeruginosa from cystic fibrosis patients: study using whole cell RAPD and antibiotic susceptibility. Pathol Biol 46 (1998) 319-324
49. Jones A.M., Govan I.R., Doherty C.J., Dodd M.E., Isalska B.J., Stanbridge T.N., et al. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 358 (2001) 557-558
50. Speert D.P., Campbell M.E., Henry D.A., Milner R., Taha F., Gravelle A., et al. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada. Am J Respir Crit Care Med 166 (2002) 988-993
51. The international Pseudomonas aeruginosa typing study group. A multicenter comparaison of methods for typing strains of Pseudomonas aeruginosa predominantly from patients with cystic fibrosis. J Infec Dis 1994;169:134-42.
52. Ito S., and Kageyama M. Relationship between pyocins and bacteriophages in Pseudomonas aeruginosa. J Gen Appl Microbiol 16 (1970) 231-240
53. Fyfe J.A.M., Harris G., and Govan J.R.W. Revisted pyocin typing method for Pseudomonas aeruginosa in a cystic fibrosis. Lancet 20 (1984) 47-50
54. Pai S.R., and Joshi L.M. Typing of Pseudomonas aeruginosa on the basis of low and high molecular weight aeruginocins. J Postgrad Med 31 (1985) 52-56
55. Sener B., Koseoglu O., Ozcelik U., Kocagoz T., and Gunalp A. Epidemiology of chronic Pseudomonas aeruginosa infectious in cystic fibrosis. Int J Med Microbiol 291 (2001) 387-393
56. Bertrand X., Thouverez M., Talon D., Boillot A., Capellier G., Floriot C., et al. Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units. Intensive Care Med 27 (2001) 1263-1268
57. Schwartz D.C., and Cantor C.R. Separation of yeast chromosome-sized DNAs by pulsed-field gradient gel electrophoresis. Cell 37 (1984) 67-75
58. Andrei A., and Zervos M.J. The application of molecular techniques to the study of hospital infection. Arch Pathol Lab Med 130 (2006) 662-668
59. Kersulyte D., Struelens M.J., Deplano A., and Berg D.E. Comparison of arbitrary primed PCR and macrorestriction (Pulsed-Field gel Electrophoresis) typing of Pseudomonas aeruginosa strains from cystic fibrosis patients. J Clin Microbiol 33 (1995) 2216-2219
60. Botes J., Williamson G., Sinickas V., and Gurtler V. Genomic typing of Pseudomonas aeruginosa isolates by comparison of riboprinting and PFGE: correlation of experimental results with those predicted from the complete genome sequence of isolate PAO1. J Microbiol Methods 55 (2003) 231-240
61. Fiona W.S., and Pitt T.L. Identification and characterisation of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. J Med Microbiol 53 (2004) 609-615
62. Kelly N.M., Fitzgerald M.X., Tempany E., O'Boyle C., Falkiner F.R., and Keane C.T. Does pseudomonas cross-infection occur between cystic-fibrosis patients. Lancet 2 (1982) 688-690
63. Rementeria A.L., Gallego L., Quindos G., and Garaizar J. Comparative evaluation of three commercial software packages for analysis of DNA polymorphism patterns. Clin Microbiol Infect 7 (2001) 331-336
64. Tenover F.C., Arbeit R.D., Goering R.V., Mickelson P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33 (1995) 2233-2239
65. Vasil M.L., Chamberlain C., and Grant C.C.R. Molecular studies of Pseudomonas aeruginosa exotoxin A gene. Infect Immun 52 (1986) 538-548
66. Blanc D.S., Siegrist H.H., Sahli R., and Francioli P. Ribotyping of Pseudomonas aeruginosa: discriminatory power and usefulness as a tool for epidemiological studies. J Clin Microbiol 31 (1993) 71-77
67. Bennekov T., Colding H., Ojeniyi B., Bentzon M.W., and Hoiby N. Comparison of ribotyping and genome fingerprinting of Pseudomonas aeruginosa isolates from cystic fibrosis patients. J Clin Microbiol 34 (1996) 202-204
68. Kristjansson M., Samore M.H., and Gerding D.N. Comparison of restriction endonuclease analysis, ribotyping, and pulsed-field gel electrophoresis for molecular differentiation of Clostridium difficile strains. J Clin Microbiol 32 (1994) 1963-1969
69. Martin C., Ait Ichou M., Massicot P., Goudeau A., and Quentin R. Genetic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis revealed by restriction fragment length polymorphism of the rRNA gene region. J Clin Microbiol 33 (1995) 1461-1466
70. Grattard F., Pozzeto B., Ros A., and Gaudin O.G. Differentiation of Pseudomonas aeruginosa strains by ribotyping: high discriminatory power by using a single restriction endonuclease. J Med Microbiol 40 (1994) 275-281
71. Denamur E.B., Picard P., Goullet P., Bingen E., Lambert N., and Elion J. Complexity of Pseudomonas aeruginosa infection in cystic fibrosis: combined results from esterase electrophoresis and rDNA restriction fragment length polymorphism analysis. Epidemiol Infect 106 (1991) 531-539
72. Pfaller M.A., Wendt C., Hollis R.J., Wenzel R.P., Fritschel S.J., Neubauer J.J., et al. Comparative evaluation of an automated ribotyping system versus pulsed-field gel electrophoresis for epidemiological typing of clinical isolates of Escherichia coli and Pseudomonas aeruginosa from patients with recurrent Gram-negative bacteremia. Diagn Microbiol Infect Dis 25 (1996) 1-8
73. Campbell M., Mahenthiralingam E., and Speert D.P. Evaluation of random amplified polymorphic DNA typing of Pseudomonas aeruginosa. J Cin Microbiol 38 (2000) 4614-4615
74. Belkum A. DNA fingerprinting of medically important microorganisms by use of PCR. Clin Microbiol Rev 7 (1994) 174-184
75. Welsh J., and McClelland. Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res 18 (1990) 7213-7218
76. Renders N., van Belkum A., Barth A., Goessens W., Mouton J., and Verbrugh I. Typing of Pseudomonas aeruginosa strains from patients with cystic fibrosis: phenotyping versus genotyping. Clin Microbiol Infect 1 (1996) 261-265
77. Tyler K.D., Wang G., Tyler S.D., and Jhonson W.M. Factors affecting reliability and reproductibility of amplification-based DNA fingerprinting of representative bacterial pathogens. (Guest commentary). J Clin Microbiol 35 (1997) 339-346
78. Meunier J.R., and Grimont P.A.D. Factors affecting reproducibility of random amplified polymorphic DNA fingerprinting. Res Microbiol 144 (1993) 373-379
79. Elaichouni A., Verschraegen G., Claeys G., Devleeschouwer M., Godard C., and Vaneechoutte M. Pseudomonas aeruginosa serotype O12 outbreak studied by arbitrary primer PCR. J Clin Microbiol 32 (1994) 666-671
80. Micheli M.R., Bova R., Calissano P., and D'Ambrosio E. Randomly amplified polymorphic DNA fingerprinting using combinations of oligonucleotide primers. Bio Techniques 15 (1993) 338-390
81. Vila J., Marcos M.A., and Jimenez de Anta M.T. A comparative study of diffrent PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus-A. baumannii complex. J Med Microbiol 44 (1996) 482-489
82. Versalovic J., Koeuth T., and Lupski J.R. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res 19 (1991) 6823-6831
83. Healy M., Houng J., Bittner T., Lising M., Frye S., Raza S., et al. Microbial DNA typing by automated repetitive-sequence-based PCR. J Clin Microbiol 43 (2005) 199-207
84. Pfaller M.A. Molecular epidemiology in the care of patients. Arch Pathol Lab Med 123 (1999) 1007-1010
85. Vernez I., Hauser P., Bernasconi M.V., and Blanc D.S. Population genetic analysis of Pseudomonas aeruginosa using multilocus sequence typing. FEMS Immunol Med Microbiol 43 (2005) 29-35
86. Maiden M.C., Bygraves J.A., Feil E., Morelli G., Russell J.E., Urwin R., et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 95 (1998) 3140-3145
87. Zaidi N., Konstantinou K., and Zervos M. The role of molecular biology and nucleic acid technology in the study of human infection and epidemiology. Arch Pathol Lab Med 127 (2003) 1098-1105
88. Aanensen D.M., and Spratt B.G. The multilocus sequence typing network: mlst.net. Nucleic Acids Res 33 (2005) 728-733
89. Feil E.J., and Enright M.C. Analyses of clonality and the evolution of bacterial pathogens. Curr Opin Microbiol 7 (2004) 308-313
90. Giske C.G., Libisch B., Colinon C., Scoulica E., Pagani L., Fuzi M., et al. Establishing clonal relationships between VIM-1-like metallo-ß-lactamase-producing Pseudomonas aeruginosa strains from four European countries by multilocus sequence typing. J Clin Microbiol 44 (2006) 4309-4315
91. Giwercman B., Lambert P.A., Rosdahl V.T., Shand G.H., and Hoiby N. Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strains. J Antimicrob Chemother 26 (1990) 247-259
92. Hernandez J., Frrus M.A., Hernandez M., and Owen R.J. Arbitrary primed PCR fingerprinting and serotyping of clinical P. aeruginosa strains. FEMS Immunol Med Microbiol 17 (1997) 37-47
93. Lewis D.A., Jones A., Parkhill J., Speert D.P., Govan J.R., Lipuma J.J., et al. Identification of DNA markers for a transmissible Pseudomonas aeruginosa cystic fibrosis strain. Am J Respir Cell Mol Biol 33 (2005) 56-64